VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, ...
Toronto, Ontario--(Newsfile Corp. - June 7, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), a company engaged in the production, growth, and sale of ...
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, ...
USC launches its historic first psilocybin clinical trial, tracking how an 8-week mindfulness meditation program enhances ...
Psilocybin has appeared in a number of biotech pipelines as the sector investigates whether psychedelics could improve treatment for certain mental health conditions. ((Arp/CC BY-SA 3.0)) Relmada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results